Folia medica Cracoviensia
-
Folia medica Cracoviensia · Jan 2001
Review[Qualification of patients for procedures to resect lung parenchyma during general anesthesia].
Authors described the methods and techniques of pulmonary and circulatory assessment of patients undergoing pulmonary resection. The most emphasis has been put on the perioperative management specially in patients with compromised pulmonary and circulatory system.
-
Folia medica Cracoviensia · Jan 2001
Clinical Trial Controlled Clinical Trial[Mivacurium--use for complications of facial-cranial surgery--personal experience].
The aim of this study was to evaluate the effectiveness of mivacurium (Mivacron--GlaxoWellcome) during combined general anaesthesia in the operations on the facial cranium, after tracheal intubation performed using suxamethonium chloride (Chlorsuccillin--Polfa PL). We examined 20 patients, 17-65 years old, who were underwent operations due to facial and neck neoplasms or trauma. Patients were divided into two 10-person groups. ⋯ By 4 patient with heart failure prolongation of the activity time of Mivacurium was observed. The dose of 0.1 mg/kg, is efficient to maintain of the neuromuscular block on the stabile level. This allows the reduction of the total dose, and the decrease of the costs of the operation.
-
Folia medica Cracoviensia · Jan 2001
Clinical Trial Controlled Clinical Trial[Does intravenous administration of magnesium have an effect on postoperative analgesia?].
The study involved 67 patients operated for malignant tumours of stomach and of the colon. The patients have been divided into 3 groups: the NORMO group--20 patients in whom the serum magnesium level remained normal during the whole period studied; the HYPO group--22 patients who developed hypomagnesaemia in the postoperative course; the MAG i.v. group--25 patients who on the day of surgery and on 4 days following surgery, received intravenously daily doses of 2.5 ml of 20% MgSO4 per each 500 ml of transfused fluids. ⋯ In all three groups, the daily amounts of morphine and noramidopirine received by patients was the same. The intravenous administration of daily doses of 8 to 14 mmol magnesium in the postoperative period does not affect the amount of analgesics given to patients.
-
Folia medica Cracoviensia · Jan 2001
Clinical Trial Controlled Clinical Trial[The effect of small doses of 7.5% NaCl on brain bulk during elective craniotomies].
In 16 patients (ASA I i II) aged 16-76 years (48 +/- 15; mean +/- SD) operated on because of intracranial expanding mass, the effect of hypertonic saline (7.5%--1 ml/kg b.w.) on brain bulk (BB) was evaluated. Patients were anaesthetised with a slight hypocarbia (PaCO2 = 33.3 +/- 3.5 mmHg). BB was scored after opening the dura (T0) and 15 min. (T15) after hypertonic saline (HS) infusion. ⋯ We can conclude that 7.5% saline in a dose of 1 ml/kg b.w. reduces brain bulk during craniotomy in patients with supratentorial mass lesions. In patients with a solid brain tumor this effect correlates negatively with a size of expanding mass. A slight changes in blood pressure and heart rate due to HS as well as moderate decrease in SK are within limits of clinical acceptance.
-
Folia medica Cracoviensia · Jan 2001
Comparative Study Clinical Trial[Sevofluran in pediatric practice--personal experience].
Sevofluran a new inhalational anesthetic is a preferred anesthetic agent for induction and maintenance of pediatric anesthesia because of its rapid induction, recovery characteristics and acceptable cardiovascular profile--now also accessible in Poland. Sevofluran isn't an ideal anesthetic, and the issue of postoperative excitement, potential nephrotoxicity requires clarification. ⋯ We didn't use higher concentrations of sevoflurane than 5.5 Vol% and 3.5 Vol% for halothane. Sevoflurane patients has a greater incidence of emergence agitation.